K.G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
J Thromb Haemost. 2021 Jul;19(7):1718-1728. doi: 10.1111/jth.15315. Epub 2021 May 7.
Several hemostatic factors and inflammatory markers are associated with the risk of incident venous thromboembolism (VTE), however, most existing data are from case-control studies in Caucasian populations.
We aimed to prospectively confirm previous findings and explore less studied biomarkers in relation to VTE risk in a multi-racial/multi-ethnic cohort.
Circulating levels of factor VIII, fibrinogen, D-dimer, plasmin-antiplasmin complex (PAP), C-reactive protein (CRP), and interleukin-6 (IL-6) were measured at baseline (2000-2002) in 6706 participants of the Multi-Ethnic Study of Atherosclerosis. Incident VTE was identified using hospitalization discharge codes from baseline to December 31, 2015. Hazard ratios (HRs) of VTE were estimated in Cox regression models.
There were 227 events during a median of 14 years of follow-up. Compared with participants in the lowest quartile, the HRs for those above the 95th percentile and p for trend across categories were 3.50 (95% confidence interval [CI] 1.98-6.19; p < .001) for D-dimer, 1.49 (95% CI 0.84-2.63; p = .02) for factor VIII, 1.32 (95% CI 0.76-2.28; p = .99) for fibrinogen, 1.92 (95% CI 1.08-3.42; p = .15) for PAP, 1.68 (95% CI 0.81-3.48; p = .08) for CRP, and 2.55 (95% CI 1.15-5.66; p = .07) for IL-6, after adjustment for demographics and body mass index. For CRP and IL-6, follow-up was restricted to 10 years because of violations of the proportional hazards assumption. No significant interactions by age/ethnicity were observed.
We demonstrated a fairly novel association between PAP and risk of incident VTE, and contributed further prospective confirmation regarding the associations of D-dimer, factor VIII, and IL-6 with VTE.
有一些止血因子和炎症标志物与静脉血栓栓塞症(VTE)的发病风险相关,然而,大多数现有数据均来自白种人病例对照研究。
我们旨在前瞻性地证实以前的研究结果,并在多民族/多种族队列中探索与 VTE 风险相关的研究较少的生物标志物。
在动脉粥样硬化多民族研究(Multi-Ethnic Study of Atherosclerosis)中,6706 名参与者于基线(2000-2002 年)时测定了因子 VIII、纤维蛋白原、D-二聚体、纤溶酶-抗纤溶酶复合物(PAP)、C 反应蛋白(CRP)和白细胞介素-6(IL-6)的循环水平。使用从基线到 2015 年 12 月 31 日的住院出院代码来确定 VTE 事件。使用 Cox 回归模型估计 VTE 的危险比(HR)。
在中位数为 14 年的随访期间,共发生 227 例事件。与处于最低四分位数的参与者相比,95%置信区间(CI)为 1.98-6.19,P<0.001)的 D-二聚体,因子 VIII 的 HRs 为 1.49(95%CI 0.84-2.63;p=0.02),纤维蛋白原的 HRs 为 1.32(95%CI 0.76-2.28;p=0.99),PAP 的 HRs 为 1.92(95%CI 1.08-3.42;p=0.15),CRP 的 HRs 为 1.68(95%CI 0.81-3.48;p=0.08),IL-6 的 HRs 为 2.55(95%CI 1.15-5.66;p=0.07),这些结果均经过人口统计学和体重指数调整。由于违反比例风险假设,CRP 和 IL-6 的随访时间限制为 10 年。未观察到年龄/种族之间存在显著的交互作用。
我们证明了 PAP 与新发 VTE 风险之间存在相当新颖的关联,并进一步前瞻性地证实了 D-二聚体、因子 VIII 和 IL-6 与 VTE 之间的关联。